# Vivodyne

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/vivodyne

- Industry: Biotechnology
- Headquarters: San Francisco, US
- Website: www.vivodyne.com
- Total disclosed funding: $80M
- Latest round: Series A (May 29, 2025)
- Investors on record: 8

## About

Based in Philadelphia, US, and founded in 2020 by co-founders Andrei Georgescu, and Dan Huh, Vivodyne Inc., provides platform technology that permits independently lab-grown, living portions of human organs to test direct drug and life-saving biologic testing on these realistic human tissues. In May 2025, Vivodyne, Inc. raised USD 40 million in series A funding led by returning investor Khosla Ventures, with participation from other returning investors Bison Ventures, CS Venture Opportunities Fund, L.P., Kairos Ventures and MBX Capital. New investors Helena, Lingotto Investment Management, Fortius Ventures, and other unspecified investors also participated in the round. The company will use the funding to open a fully automated human tissue testing facility and expand preclinical testing capacity for pharmaceutical partners.

## Funding rounds

- Series A, May 29, 2025, $40M — Khosla Ventures, Kairos Ventures, MBX Capital, Helena, Bison Ventures, Fortius Ventures, Lingotto Investment Management LLP, CS Venture Opportunities Fund, L.P.
- Seed, Nov 22, 2023, $38M — Khosla Ventures, Kairos Ventures, MBX Capital, Bison Ventures, CS Venture Opportunities Fund, L.P.
- Seed, Mar 4, 2021, $2M — Kairos Ventures

## Investors

- Kairos Ventures (https://capitalatlas.ai/funds/kairos-ventures) — Seed, Series A
- Khosla Ventures (https://capitalatlas.ai/funds/khosla-ventures) — Seed, Series A
- MBX Capital (https://capitalatlas.ai/funds/mbx-capital) — Seed, Series A
- Bison Ventures (https://capitalatlas.ai/funds/bison-ventures) — Seed, Series A
- CS Venture Opportunities Fund, L.P. — Seed, Series A
- Helena (https://capitalatlas.ai/funds/helena) — Series A
- Fortius Ventures (https://capitalatlas.ai/funds/fortius-ventures) — Series A
- Lingotto Investment Management LLP — Series A